Clinical Trials Browser

Phase 2 × Advanced NSCLC × 90 days × Clear all

NCT06924606 2026-02-06

Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy

Phase 2 Recruiting

Advanced NSCLC